Key points are not available for this paper at this time.
Surveillance for PDAC in carriers of a CDKN2A/p16 pathogenic variant results in earlier detection, increased resectability, and improved survival as compared with non-surveillance patients with PDAC.
Klatte et al. (Mon,) studied this question.